|
ID
Biomedical Corporation
|
Toronto
Stock Exchange (IDB) NASDAQ Market (symbol “IDBE”)
ID
Biomedical Corporation is a biotechnology company focused on the development
of proprietary subunit vaccine products, including those based on its platform
intranasal adjuvant/delivery technology, Proteosomes. ID Biomedical has
also developed a proprietary genomics analysis system, Cycling ProbeTechnology
(CPT).
http://www.idbiomed.com
1510-800 West Pender Street
Vancouver, BC V6C 2, Canada
Phone: (604) 431-9314 Fax:
(604) 431-9378 |
